Healthpoint celebrates milestone of 100 robotically assisted surgeries

• perform total knee, uni knee, patellofemoraland hip replacements

The Makotechnology can be used for total knee, uni knee, patellofemoral,and hip replacements.It provides greater accuracy, better outcomes, faster recovery, and less pain for patients in comparison to replacements done with traditional techniques. This type of robotic surgery is widely offered abroad.

The technology was brought to Healthpoint by one of the most prominent orthopedic robotic surgeonsin the industry. UK-based Dr. Jonathan Conroyspecializes in robotic-assisted hip and knee surgery, and has extensive experience, offering procedures such as arthroscopic hip surgery and standard joint replacements.

The orthopedic robotic arm-assisted surgery technique allows surgeons to prepare for joint replacement operations with more precision and accuracy. After a patient undergoes a CT scan, a 3D model is generated using digital technology that can be viewed from all angles on a computer screen. This innovative technology provides a unique opportunity for the surgeon to visualize and anticipate how the hip or knee joint will functionally move. By assessing the joint replacement prior to surgery, the medical team can determine the optimal surgical approach to take. This ensures that the surgical plan is thoroughly modeled and evaluated before any procedure is performed.

In addition to treating several patients in the emirates, the hospital treated patients from around the globe,including patients fromthe United States, Kuwait,and Egypt. The youngest patient, at 15 years of age, underwenttotal hip replacement, and the oldest, at 84,had a total knee replacement.

Some of the surgeries have helped young patients with developmental deformities or complex injuries after trauma. Recovery was noticeably quicker, but still depends on age, the commitment of the patient to work with a physiotherapist,and the complexity of thesurgery. Some patients were able to return to work after two weeks; but generally, most recover within six weeks after surgery.

Dr. Hasan Elias Baydoun, consultant orthopedic surgeon and head of orthopedic department at Healthpointsaid:“The ‘Mako’ robotic arm can perform extremely accurate incisions on the bone, which has been proven to result in a quicker recovery and better long-term results. We have received positive feedback from patients regarding the speed of their recovery, having good knee flexion, and experiencingbetter-than-expected outcomes in terms of returning to work and day-to-day activities.”

“We have seen patients who undergo robotic surgery being able to go home the very same day.”

All joints can get osteoarthritis. Osteoarthritis can develop in any of the body’s joints. The knee joint is the one most commonly affected with osteoarthritis, often resulting in severe symptoms that require joint replacement surgery. In the near future, Healthpoint also expects to introduce shoulder replacements.

ENDS

About Healthpoint

Focusing on a carefully defined set of medically integrated services and practices, Healthpoint patient-centered approach is organized around medical conditions over the full cycle of care and delivered in integrated practice units (IPUs).

Committed to elevating patient care to the highest standards, Healthpoint has been recognized by numerous renowned international awarding and accrediting bodies. These include the Commission on Accreditation of Rehabilitation Facilities (CARF International), the Joint Commission International (JCI), the Australian Council on Healthcare Standards International (ACHSI), and the American Surgical Review Corporation (SRC).

About M42

M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing innovative solutions, unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care.

M42 has over 20,000 employees and more than 450 facilities in 24 countries around the world. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 is a first-of-its-kind integrated healthcare company that combines unique medical and data-centric technologies with state-of-the-art facilities to deliver world-class care.

M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and The National Reference Laboratory, among others.